Opportunity Information: Apply for PAR 11 005
Apply for PAR 11 005
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Cancer Center Support Grants (CCSGs) for NCI designated Cancer Centers (P30)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.397 Cancer Centers Support Grants.
- This funding opportunity was created on Oct 12, 2010 and posted on Oct 12, 2010.
- Applicants must submit their applications by Sep 7, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Cancer Center Support Grants (CCSGs) funding opportunity (P30 mechanism) is a National Cancer Institute (NCI), NIH program designed to support NCI-designated Cancer Centers through either new (competing) or renewal (competing) applications. The central idea is not to fund individual research projects, but to strengthen and organize an institution's overall cancer research enterprise by providing resources, infrastructure, and coordination that allow a cancer center to operate as a unified, high-impact hub for cancer discovery and translation.
This FOA supports two categories of NCI-designated centers. The first is the Comprehensive Cancer Center, which must show meaningful depth and breadth across three major scientific domains: laboratory research, clinical research, and population-based research. Beyond simply having activity in each area, comprehensive centers are expected to demonstrate substantial transdisciplinary work that bridges these domains, for example connecting basic mechanistic discoveries to clinical trials and to population-level prevention or outcomes research. The second category is the Cancer Center (non-comprehensive), which may focus primarily on laboratory research, clinical research, population science, or a combination of these components, without necessarily meeting the full breadth and bridging expectations required for comprehensive designation.
Across both center types, the purpose is to consolidate and elevate the institution's cancer research capabilities by integrating strong programs in laboratory, clinical, and population research (as applicable) into a single coordinated, transdisciplinary enterprise. A key emphasis is working across institutional and departmental boundaries so that the center functions as an organizing structure that aligns scientific priorities, promotes collaboration, and reduces fragmentation. In practical terms, CCSGs are meant to help cancer centers become major engines for understanding cancer biology and for developing better approaches to cancer prevention, diagnosis, and treatment.
The FOA also makes clear what is expected of centers supported by the P30 CCSG mechanism. These cancer centers should serve as major sources of discovery and innovation, and they are expected to make significant contributions through the development and maintenance of shared resources that support research across the center (for example, core facilities, shared technologies, or coordinated support services that multiple investigators rely on). In addition, centers are expected to collaborate and coordinate with other NCI-funded programs and investigators, which reinforces the idea that the cancer center should function as part of a broader national research ecosystem rather than as a standalone institution. Another explicit expectation is dissemination of research findings for community benefit, reflecting the public-facing responsibility of NCI-designated centers to ensure that scientific advances translate into real-world improvements.
From an administrative and funding standpoint, this opportunity uses the NIH center grant (P30) mechanism, and awards are discretionary and contingent on both the availability of federal funds and the receipt of a sufficient number of meritorious applications. There is no cost sharing or matching requirement listed. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, and nonprofit organizations (both with and without 501(c)(3) status), as specified in the opportunity details.
Key identification details from the listing include Funding Opportunity Number PAR-11-005, CFDA number 93.397 (Cancer Centers Support Grants), and an original posting date of October 12, 2010. The opportunity was later archived (archive date October 8, 2013), with closing dates listed in the record as September 7, 2013 (current closing at the time) and September 25, 2014 (original closing). Additional program details were provided through the NIH Grants Guide link associated with the FOA, and technical access issues were directed to the NIH Office of Extramural Research (OER) webmaster contact.
Frequently Asked Questions (FAQs)
What is the Cancer Center Support Grants (CCSGs) funding opportunity?
The Cancer Center Support Grants (CCSGs) funding opportunity is a National Cancer Institute (NCI), NIH program that uses the NIH center grant (P30) mechanism to support NCI-designated Cancer Centers. It supports either new (competing) applications or renewal (competing) applications.
What is the main purpose of a CCSG (P30) award?
The central purpose is not to fund individual research projects. Instead, CCSGs are intended to strengthen and organize an institution's overall cancer research enterprise by providing resources, infrastructure, and coordination so the cancer center can operate as a unified, high-impact hub for cancer discovery and translation.
Does this funding opportunity pay for individual research projects?
No. The FOA emphasizes that the P30 CCSG mechanism is designed to support resources, infrastructure, shared services, and coordination that elevate the center as an integrated enterprise, rather than directly funding individual research projects.
What types of NCI-designated centers are supported under this FOA?
This FOA supports two categories of NCI-designated centers: (1) Comprehensive Cancer Centers and (2) Cancer Centers (non-comprehensive).
What is an NCI-designated Comprehensive Cancer Center under this opportunity?
A Comprehensive Cancer Center is expected to demonstrate meaningful depth and breadth across three major scientific domains: laboratory research, clinical research, and population-based research. These centers are also expected to show substantial transdisciplinary work that bridges these domains, such as linking basic discoveries to clinical trials and to population-level prevention or outcomes research.
What is an NCI-designated Cancer Center (non-comprehensive) under this opportunity?
A Cancer Center (non-comprehensive) may focus primarily on laboratory research, clinical research, population science, or a combination of these components. It is not required to meet the full breadth and bridging expectations described for comprehensive designation.
What does the FOA mean by a "transdisciplinary enterprise" for cancer centers?
In this FOA, the idea of a transdisciplinary enterprise includes integrating and coordinating research efforts across laboratory, clinical, and population-based research (as applicable), and working across institutional and departmental boundaries so the center functions as an organizing structure rather than a collection of separate, fragmented activities.
What kinds of activities or capabilities does the CCSG aim to strengthen?
The CCSG is intended to consolidate and elevate an institution's cancer research capabilities by supporting resources, infrastructure, shared resources, and coordination that help the cancer center operate as a unified hub for understanding cancer biology and developing improved approaches to cancer prevention, diagnosis, and treatment.
What is expected of cancer centers supported by the P30 CCSG mechanism?
The FOA states that supported cancer centers should serve as major sources of discovery and innovation. They are expected to make significant contributions through shared resources that support research across the center, coordinate with other NCI-funded programs and investigators, and disseminate research findings for community benefit.
What are "shared resources" in the context of this CCSG FOA?
Shared resources refer to center-supported capabilities that multiple investigators rely on, such as core facilities, shared technologies, or coordinated support services that enable research across the cancer center rather than serving only a single project or investigator.
Is collaboration with other NCI-funded programs part of the expectations?
Yes. The FOA explicitly states that centers are expected to collaborate and coordinate with other NCI-funded programs and investigators, reinforcing that NCI-designated centers function as part of a broader national research ecosystem.
Does the FOA include expectations around dissemination or community benefit?
Yes. Another explicit expectation described is dissemination of research findings for community benefit, reflecting a public-facing responsibility to help translate scientific advances into real-world improvements.
What grant mechanism is used for this opportunity?
This opportunity uses the NIH center grant (P30) mechanism.
Are awards guaranteed under this FOA?
No. The FOA indicates that awards are discretionary and contingent on the availability of federal funds and the receipt of a sufficient number of meritorious applications.
Is cost sharing or matching required?
No cost sharing or matching requirement is listed in the information provided for this opportunity.
Who is eligible to apply for this grant opportunity?
Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, and nonprofit organizations (both with and without 501(c)(3) status), as specified in the opportunity details.
What is the Funding Opportunity Number (FOA number) for this program?
The Funding Opportunity Number listed is PAR-11-005.
What is the CFDA number associated with Cancer Centers Support Grants?
The CFDA number provided is 93.397 (Cancer Centers Support Grants).
When was this opportunity originally posted, and is it still active?
The original posting date listed is October 12, 2010. The record also indicates the opportunity was later archived, with an archive date of October 8, 2013.
What closing dates are listed in the record?
The record lists closing dates as September 7, 2013 (the current closing at the time in the record) and September 25, 2014 (the original closing).
Where were additional program details provided?
Additional program details were provided through the NIH Grants Guide link associated with the FOA.
Who is referenced for technical access issues related to the opportunity information?
Technical access issues were directed to the NIH Office of Extramural Research (OER) webmaster contact, as noted in the listing.
Browse more opportunities from the same category: Education Health
Next opportunity: DoD Breast Cancer Postdoctoral Fellowship Award
Previous opportunity: Utilization of a Human Lung Tissue Resource for Vascular Research (R03)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 11 005
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 11 005) also looked into and applied for these:
| Funding Opportunity |
|---|
| Comprehensive Partnerships to Reduce Cancer Health Disparities (U54) Apply for RFA CA 11 001 Funding Number: RFA CA 11 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Translational Scholar Career Awards in Pharmacogenomics and Personalized Medicine (K23) Apply for PA 11 009 Funding Number: PA 11 009 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Substance Use and Abuse, Risky Decision Making and HIV/AIDS (R03) Apply for PA 11 008 Funding Number: PA 11 008 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Substance Use and Abuse, Risky Decision Making and HIV/AIDS (R01) Apply for PA 11 006 Funding Number: PA 11 006 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Substance Use and Abuse, Risky Decision Making and HIV/AIDS (R21) Apply for PA 11 007 Funding Number: PA 11 007 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| HIV Infection of the Central Nervous System (R01) Apply for PA 11 014 Funding Number: PA 11 014 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| National Gene Vector Biorepository and Coordinating Center (P40) Apply for RFA RR 10 010 Funding Number: RFA RR 10 010 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Medical Marijuana Policy Research Exploring Trends and Impacts (R01) Apply for RFA DA 11 008 Funding Number: RFA DA 11 008 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Molecular Genetics of Drug Addiction and Related Co Morbidities (R01) Apply for PA 11 026 Funding Number: PA 11 026 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Support Opportunity for Addiction Research (SOAR) for New Investigators (R03) Apply for RFA DA 11 010 Funding Number: RFA DA 11 010 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| The Development Of Frontal Cortex And Limbic System And Their Roles In Drug Abuse (R01) Apply for PA 11 027 Funding Number: PA 11 027 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Continued Development and Maintenance of Software (R01) Apply for PAR 11 028 Funding Number: PAR 11 028 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Statistical Coordination Center for the Population based Research Optimizing Screening through Personalized Regimens (PROSPR)(U01) Apply for RFA CA 11 004 Funding Number: RFA CA 11 004 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Population based Research Optimizing Screening through Personalized Regimens (PROSPR) (U54) Apply for RFA CA 11 003 Funding Number: RFA CA 11 003 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Functional Genetics, Epigenetics, and Non coding RNAs in Drug Addiction (R21) Apply for PA 11 034 Funding Number: PA 11 034 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Functional Genetics, Epigenetics, and Non coding RNAs in Drug Addiction (R03) Apply for PA 11 035 Funding Number: PA 11 035 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Institutional Clinical and Translational Science Award (U54) Apply for RFA RM 10 020 Funding Number: RFA RM 10 020 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Limited Competition Fogarty International Research Collaboration Behavioral and Social Sciences (FIRCA BSS) Research Award (R03) Apply for PAR 11 036 Funding Number: PAR 11 036 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R01) Apply for PA 11 047 Funding Number: PA 11 047 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R21) Apply for PA 11 048 Funding Number: PA 11 048 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 11 005", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
